The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 112: 573-582.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, D. C.
Right arrow Articles by Cochrane, C. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Morrison, D. C.
Right arrow Articles by Cochrane, C. G.

Activation of Rat Mast Cells by Low Molecular Weight Stimuli1

D. C. Morrison2, J. F. Roser, P. M. Henson3 and C. G. Cochrane

From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

Radiolabeled mast cell activators, compound 48/80, and a cationic protein from neutrophils were shown to bind almost exclusively to mast cells in suspensions of rat peritoneal cells. A correlation was obtained between the binding of activator and release of 3H-serotonin at low concentrations of activator. It was shown that activator binding was substantially enhanced by the release process itself, thus demonstrating that release of amines exposes new sites for binding of activator. Saturation binding studies using compound 48/80 indicated that approximately 6x1010 molecules of activator could be bound per mast cell under conditions in which release of vasoactive amines occurs. A third mast cell activator, polymyxin B, was shown to compete with compound 48/80 for binding to mast cells.

A technique has also been described for determining accurately the release of amines from mast cells. 3H-serotonin was incorporated in mast cells in vitro and specifically released by agents which stimulate the cells.

Footnotes

1 This is publication 745 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, 476 Prospect Street, La Jolla, California. This work was supported by the United States Public Health Service Grant AI-07007, the American Heart Association, the Council for Tobacco Research, and GMS Grant GM19322-02.

2 Supported by United States Public Health Service Training Grant 5-T01-GM00683-13.

3 Recipient of United States Public Health Service Career Development Award GM42567-04.




This article has been cited by other articles:


Home page
BloodHome page
H. Tapper and H. Herwald
Modulation of hemostatic mechanisms in bacterial infectious diseases
Blood, October 1, 2000; 96(7): 2329 - 2337.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. I. Rudolph, C. Oviedo, E. Vega, L. Martínez, K. Reinicke, M. Villar, and L. Villán
Oxytocin Inhibits the Uptake of Serotonin into Uterine Mast Cells
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 389 - 394.
[Abstract] [Full Text]


Home page
ScienceHome page
T. Theoharides, W Sieghart, P Greengard, and W. Douglas
Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein
Science, January 4, 1980; 207(4426): 80 - 82.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.